Literature DB >> 11814093

Left ventricular assist device infections: three case reports and a review of the literature.

Kumudhini Sivaratnam1, Joan M Duggan.   

Abstract

Left ventricular assist device (LVAD) infections are a major device complication and are associated with significant morbidity. We report three cases of LVAD infections in our institution and review the literature to assess clinical parameters associated with infection, causative organisms, treatment modalities, and patient outcomes. A total of 46 cases were reviewed. Fever, leukocytosis, and drainage from the exit site were the most commonly reported symptoms. Left ventricular assist devices were in place an average of 65 days before the onset of infection. The most common site of LVAD infection was the drive line. Staphylococcus aureus was the most common organism, followed by gram negative rods, Candida, and enterococcus species and coagulase negative Staphylococcus. Treatment consisted primarily of surgical intervention, including incisional debridement, pump pocket exploration, and LVAD replacement and adjunctive intravenous antibiotics, especially vancomycin. Only eight infected patients died before transplantation, with five deaths due to sepsis. Four of these five patients were infected with a gram negative rod. In general, patients who developed an LVAD infection were able to undergo successful transplantation without recurrence, but infection with a gram negative rod was associated with a poor outcome.

Entities:  

Mesh:

Year:  2002        PMID: 11814093     DOI: 10.1097/00002480-200201000-00002

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  7 in total

1.  Cardiovascular implantable device infections.

Authors:  George M Viola; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

2.  Infection management in a patient with a left ventricular assist device: a case report of long-term cefazolin sodium hydrate administration.

Authors:  Eiki Tayama; Koichi Arinaga; Takahiro Shojima; Kazuyoshi Takagi; Yoshinori Yokokura; Kazuhiro Yoshikawa; Hidetsugu Hori; Shuji Fukunaga; Hidetoshi Akashi; Shigeaki Aoyagi
Journal:  J Artif Organs       Date:  2006       Impact factor: 1.731

3.  Infectious Complications of Mechanical Circulatory Support (MCS) Devices.

Authors:  Stanley I Martin
Journal:  Curr Infect Dis Rep       Date:  2013-09-29       Impact factor: 3.725

4.  Prospective, multicenter study of ventricular assist device infections.

Authors:  Rachel J Gordon; Alan D Weinberg; Francis D Pagani; Mark S Slaughter; Pat S Pappas; Yoshifumi Naka; Daniel J Goldstein; Walter P Dembitsky; Julie C Giacalone; Jennifer Ferrante; Deborah D Ascheim; Alan J Moskowitz; Eric A Rose; Annetine C Gelijns; Franklin D Lowy
Journal:  Circulation       Date:  2013-01-11       Impact factor: 29.690

Review 5.  Endocarditis in left ventricular assist device.

Authors:  Braghadheeswar Thyagarajan; Monisha Priyadarshini Kumar; Rutuja R Sikachi; Abhinav Agrawal
Journal:  Intractable Rare Dis Res       Date:  2016-08

Review 6.  Perioperative pharmacotherapy in patients with left ventricular assist devices.

Authors:  Nicholas C Dang; Yoshifumi Naka
Journal:  Drugs Aging       Date:  2004       Impact factor: 4.271

7.  Therapy and Outcome of Staphylococcus aureus Infections of Intracorporeal Ventricular Assist Devices.

Authors:  Miquel B Ekkelenkamp; Mats T Vervoorn; Jumamurat R Bayjanov; Ad C Fluit; Barry J Benaissa-Trouw; Faiz Z Ramjankhan
Journal:  Artif Organs       Date:  2018-04-19       Impact factor: 3.094

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.